Infectious Diseases Trial of a Long-Acting Malaria Drug Injection Launches in RwandaGlobal Biodefense StaffNovember 5, 2026
CBRNE Radiation Countermeasure Entolimod Clears Mouse Safety Study, Moves to Survival TestGlobal Biodefense StaffNovember 3, 2026
Medical Countermeasures UK Commits £33.2 Million to Eight Vaccine Projects Targeting Ebola, Marburg, Plague and Other Epidemic ThreatsGlobal Biodefense StaffOctober 18, 2026
DHS Seeks Contractor for Agricultural Biodefense Efforts at Plum Island Biosecurity February 6, 2013 …
Tetravalent Dengue Vaccine Candidate Shows Promise in Early Trials Medical Countermeasures January 28, 2013 …
Emergent BioSolutions Secures Rights to Pandemic Influenza Vaccine Candidate Industry News January 8, 2013 …
DARPA Supports Research on Pollen for Oral Vaccine Delivery Medical Countermeasures November 28, 2012 …
Army Dengue Vaccine Trial Supported by State University of New York Industry News November 28, 2012 …
Novartis Receives FDA Approval for First Cell-Culture Influenza Vaccine Industry News November 23, 2012 …
Open Access Initiative Helps Neglected Tropical Disease Drug Effort Industry News November 13, 2012 …
NIH, CDC Small Business Innovation for Medical Countermeasures Contracts + Grants November 12, 2012 …